Researchers have found that the brain uses different processes to enter and exit anesthetic-induced unconsciousness. The new study indicates that the pathways into and out of drug-induced unconsciousness are not identical, and that a delay often occurs before consciousness returns even after anesthetic levels fall.
Penn study sheds light on how the brain shifts between sleep and wakefulness under anesthesia
Although approximately 25 million patients in the United States undergo general anesthesia each year, the precise ways anesthetic drugs interact with the central nervous system have remained largely theoretical. Researchers at the University of Pennsylvania School of Medicine now report that, in animal models, transitions into and out of anesthetic-induced unconsciousness follow distinct trajectories. Published in PLoS One, the study identifies a conserved neural property that may help explain why emergence from anesthesia can lag behind decreases in drug concentration and what governs transitions between conscious and unconscious states.
“One major unanswered question in neuroscience is how the brain transitions between conscious and unconscious states,” said senior author Max B. Kelz, MD, PhD, assistant professor of Anesthesiology and Critical Care. “Our results suggest the brain tracks whether it is awake or offline and resists switching states under certain conditions. By studying anesthetics in controlled animal models, we can probe the mechanisms behind this behavioral barrier that separates consciousness from unconsciousness.”
Traditionally, induction of anesthesia has been attributed to drug-driven changes in neuronal activity, while emergence was viewed as a passive process driven by the elimination of anesthetic from central nervous system sites. If induction and emergence were truly mirror processes, equivalent concentrations of anesthetic in the CNS would produce identical effects in both directions. The Penn team’s experiments show this is not the case.
Using dose–response measurements in both fruit flies and mice, the researchers demonstrated that the forward path into anesthesia and the reverse path back to wakefulness differ. After animals transitioned from wakefulness into an anesthetic-induced unconscious state, they exhibited resistance to immediately returning to wakefulness—even when anesthetic concentration was reduced. This hysteresis-like behavior led the authors to propose a biologically conserved state they term “neural inertia,” defined as the central nervous system’s tendency to resist transitions between conscious and unconscious states.
The neural inertia concept provides a unifying framework for several observations: why some patients experience delayed recovery of consciousness despite falling anesthetic levels, why arousal thresholds can remain elevated after exposure to sedatives, and how the brain may maintain stability of behavioral state once a transition occurs. The team emphasizes that neural inertia is not a single molecular pathway but likely the result of network-level interactions and modulatory influences that stabilize either the awake or unconscious state.
Beyond anesthesia, these findings have implications for sleep research and for clinical conditions in which recovery of consciousness is impaired. “Understanding neural inertia could shed light on normal sleep–wake regulation as well as pathological states such as certain comas and disorders of consciousness,” Kelz said. “In the long term, this work may help guide development of anesthetic agents and targeted therapies for patients with sleep disorders or those who are unable to regain consciousness after severe brain injury.”
The study was carried out by a multidisciplinary team from the University of Pennsylvania School of Medicine, including researchers from departments and centers focused on anesthesiology, critical care, sleep and respiratory neurobiology, pharmacology, and translational medicine.
Editors’ notes:
This research received partial support from an American Recovery and Reinvestment Act grant. Additional funding came from the National Institute for General Medical Sciences, the Foundation for Anesthesia Education and Research, the University of Pennsylvania Institute for Translational Medicine and Therapeutics, the Harold Amos Medical Faculty Development Program (R.W. Johnson Foundation), the Parker B. Francis Fellowship program, and the University of Pennsylvania Department of Anesthesiology and Critical Care.
Penn Medicine is a leading academic medical center that combines medical education, biomedical research, and patient care. It comprises the University of Pennsylvania School of Medicine (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System. Penn’s School of Medicine is ranked among the top research-oriented medical schools in the country and has been a consistent recipient of NIH research funding.
Penn Medicine’s patient-care network includes major hospitals and specialty centers across the Philadelphia region. Key facilities include:
- The Hospital of the University of Pennsylvania, a long-standing academic teaching hospital recognized nationally for clinical excellence.
- Penn Presbyterian Medical Center, known for cardiovascular care and other specialties.
- Pennsylvania Hospital, the nation’s first hospital, recognized for orthopaedics, obstetrics and gynecology, and behavioral health.
In addition to hospitals, Penn Medicine operates outpatient clinics, rehabilitation and specialty services, a primary care network, home care and hospice programs, and community health initiatives. In fiscal year 2008, Penn Medicine reported substantial community benefit and outreach funding.
Contact: Jessica Mikulski
Source: University of Pennsylvania School of Medicine